Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25378704.
- Also identified by DOI 10.1073/pnas.1403234111 and PMC identifier 4246349.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have developed a screening platform for the isolation of genetic entities involved in metastatic reactivation. Retroviral libraries of cDNAs from fully metastatic breast-cancer cells or pooled microRNAs were transduced into breast-cancer cells that become dormant upon infiltrating the lung. Upon inoculation in the tail vein of mice, the cells that had acquired the ability to undergo reactivation generated metastatic lesions. Integrated retroviral vectors were recovered from these lesions, sequenced, and subjected to a second round of validation. By using this strategy, we isolated canonical genes and microRNAs that mediate metastatic reactivation in the lung. To identify genes that oppose reactivation, we screened an expression library encoding shRNAs, and we identified target genes that encode potential enforcers of dormancy. Our screening strategy enables the identification and rapid biological validation of single genetic entities that are necessary to maintain dormancy or to induce reactivation. This technology should facilitate the elucidation of the molecular underpinnings of these processes.
Medical subject headings
- Gene Expression Regulation, Neoplastic
- Genes, Neoplasm
- High-Throughput Screening Assays
- Mammary Neoplasms, Experimental
- Neoplasm Metastasis